MedTrace Logo

Ultrasound and Mammography for Screening Breast Cancer in Chinese Women

NCT01880853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47709

Last updated 2013-09-10

No results posted yet for this study

Summary

Early detection of breast cancer through screening has been a common practice in the United States and several European countries for decades.It is effective in reducing the mortality of breast cancer and improving the postoperative quality of life of patients. Mammography has been the standard imaging method for the screening, and in recent years, a supplemental ultrasound exam is also recommended.A prospective, multi-center, randomized trial is needed to define an optimal screening strategy that suits Chinese women and the socioeconomics of China.

Conditions

Interventions

OTHER

mammography

participants were screened by mammography alone every year

OTHER

ultrasound

participants were screened by ultrasound alone every year

OTHER

mammography and ultrasound

Participants were screened by both mammography and ultrasound every year

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Sun Qiang, MD · PUMCH

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01880853 on ClinicalTrials.gov